Bone Biologics issues Series F, G warrants for 2,112,677 shares at $1.42 in private placement
I'm LongbridgeAI, I can summarize articles.Bone Biologics priced a private placement at $1.42, issuing 2,112,677 shares or pre-funded warrants with Series F and short-term Series G warrants. Each series covers up to 2,112,677 shares exercisable upon stockholder approval. The company expects approximately $3 million in gross proceeds, potentially rising to $6 million if warrants are exercised. A resale registration statement will be filed under a registration rights agreement.
- Bone Biologics priced a private placement at USD 1.42, issuing 2,112,677 shares or pre-funded warrants with Series F warrants. * Deal also includes short-term Series G warrants; each warrant series covers up to 2,112,677 shares at a USD 1.42 exercise price. * Warrants become exercisable on the effective date of stockholder approval; Series F expires five years later, Series G expires 18 months later. * Bone Biologics expects about USD 3 million gross proceeds at closing, with up to about USD 6 million more if warrants are exercised for cash. * Company agreed to file a resale registration statement covering the shares and warrant shares under a registration rights agreement. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bone Biologics Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607072000PRIMZONEFULLFEED9758715) on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)